Targeting chronic and neuropathic pain: The N-type calcium channel comes of age

No abstract is available for this paper.

• Publication year

  2005

• Venue

  NeuroRx

• Publication date

  2005-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1602/neurorx.2.4.662PMID 16489373PMCID PMC1201323
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Calcium Channel Pharmacology

  2012cited by this paper
• Biochemical Studies of Voltage-Gated Ca2+ Channels

  2005cited by this paper
• Antinociceptive effects of intrathecally administered huwentoxin-I, a selective N-type calcium channel blocker, in the formalin test in conscious rats.

  2005cited by this paper
• Medullary N-type and P/Q-type calcium channels contribute to neuropathy-induced allodynia

  2005cited by this paper
• Involvement of different calcium channels in the depolarization-evoked release of noradrenaline from sympathetic neurones in rabbit carotid artery.

  2005cited by this paper
• Molecular Properties of Voltage-Gated Calcium Channels

  2005cited by this paper
• Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial.

  2004cited by this paper
• Modulation of High Voltage-Activated Calcium Channels by G Protein-Coupled Receptors

  2004cited by this paper
• Antinociceptive effect of different types of calcium channel inhibitors and the distribution of various calcium channel alpha 1 subunits in the dorsal horn of spinal cord in mice.

  2004cited by this paper
• Differential involvement of N‐type calcium channels in transmitter release from vasoconstrictor and vasodilator neurons

  2004cited by this paper
• Determinants of Inhibition of Transiently Expressed Voltage-gated Calcium Channels by ω-Conotoxins GVIA and MVIIA*

  2003cited by this paper
• The novel N‐type calcium channel blocker, AM336, produces potent dose‐dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices

  2002cited by this paper
• Molecular Determinants of Syntaxin 1 Modulation of N-type Calcium Channels*

  2002cited by this paper
• Chronic pain and medullary descending facilitation.

  2002cited by this paper
• Effects of ablation of N- and R-type Ca(2+) channels on pain transmission.

  2002cited by this paper
• Actions of intrathecal omega-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat.

  2002cited by this paper
• Altered Nociceptive Response in Mice Deficient in the α1B Subunit of the Voltage-Dependent Calcium Channel

  2001cited by this paper
• Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N‐type Ca2+ channel

  2001cited by this paper
• Altered nociceptive response in mice deficient in the alpha(1B) subunit of the voltage-dependent calcium channel.

  2001cited by this paper
• Distinct Molecular Determinants Govern Syntaxin 1A-Mediated Inactivation and G-Protein Inhibition of N-Type Calcium Channels

  2001cited by this paper
• Functional disorders of the sympathetic nervous system in mice lacking the α1B subunit (Cav 2.2) of N-type calcium channels

  2001cited by this paper
• Novel ω-Conotoxins from Conus catus Discriminate among Neuronal Calcium Channel Subtypes*

  2000cited by this paper
• Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N‐type voltage‐sensitive calcium channels, with morphine on nociception in rats

  2000cited by this paper
• Coexpression of cloned alpha(1B), beta(2a), and alpha(2)/delta subunits produces non-inactivating calcium currents similar to those found in bovine chromaffin cells.

  2000cited by this paper
• Ziconotide: A New Pharmacological Class of Drug for the Management of Pain

  2000cited by this paper
• Ziconotide for the treatment of severe spasticity after spinal cord injury.

  2000cited by this paper
• Coexpression of Cloned α1B, β2a, and α2/δ Subunits Produces Non-Inactivating Calcium Currents Similar to Those Found in Bovine Chromaffin Cells

  2000cited by this paper
• Effects of antagonists to high‐threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia

  2000cited by this paper
• Effects of intrathecal administration of ziconotide, a selective neuronal N‐type calcium channel blocker, on mechanical allodynia and heat hyperalgesia in a rat model of postoperative pain

  2000cited by this paper
• Multiple neuropeptide Y receptors regulate K+ and Ca2+ channels in acutely isolated neurons from the rat arcuate nucleus.

  1999cited by this paper
• Alternative Splicing of a Short Cassette Exon in α1B Generates Functionally Distinct N-Type Calcium Channels in Central and Peripheral Neurons

  1999cited by this paper
• Splicing of alpha 1A subunit gene generates phenotypic variants of P- and Q-type calcium channels.

  1999cited by this paper
• Splicing of α1A subunit gene generates phenotypic variants of P- and Q-type calcium channels

  1999cited by this paper
• Hyperalgesia and allodynia induced by intrathecal (RS)‐dihydroxyphenylglycine in rats

  1998cited by this paper
• mu-opioid receptor activation inhibits N- and P-type Ca2+ channel currents in magnocellular neurones of the rat supraoptic nucleus.

  1998cited by this paper
• Localization of Ca2+ Channel Subtypes on Rat Spinal Motor Neurons, Interneurons, and Nerve Terminals

  1998influential reference
• Decay of prepulse facilitation of N type calcium channels during G protein inhibition is consistent with binding of a single Gbeta subunit.

  1998cited by this paper
• Preferential Interaction of ω-Conotoxins with Inactivated N-type Ca2+ Channels

  1997cited by this paper
• Sympatholysis after neuron-specific, N-type, voltage-sensitive calcium channel blockade: first demonstration of N-channel function in humans.

  1997cited by this paper
• [Calcium channels].

  1997cited by this paper
• Use of intrathecal SNX-111, a novel, N-type, voltage-sensitive, calcium channel blocker, in the management of intractable brachial plexus avulsion pain.

  1997cited by this paper
• Identification of functionally distinct isoforms of the N-type Ca2+ channel in rat sympathetic ganglia and brain.

  1997cited by this paper
• Crosstalk between G proteins and protein kinase C mediated by the calcium channel α1 subunit

  1997cited by this paper
• Preferential interaction of omega-conotoxins with inactivated N-type Ca2+ channels.

  1997cited by this paper
• Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system.

  1996cited by this paper
• Differential regulation of evoked peptide release by voltage-sensitive calcium channels in rat sensory neurons.

  1996cited by this paper
• Elementary events underlying voltage-dependent G-protein inhibition of N-type calcium channels.

  1996cited by this paper
• Determinants of the G protein-dependent opioid modulation of neuronal calcium channels.

  1996cited by this paper
• Exocytotic Ca2+ channels in mammalian central neurons.

  1995cited by this paper
• Determinants of PKC-dependent modulation of a family of neuronal calcium channels.

  1995cited by this paper
• Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalin-induced nociception

  1994cited by this paper
• Neuroanatomical distribution of receptors for a novel voltage-sensitive calcium-channel antagonist, SNX-230 (omega-conopeptide MVIIC).

  1994cited by this paper
• Neuroanatomical distribution of receptors for a novel voltage-sensitive calcium channel antagonist, SNX-230 (ω-conopeptide MVIIC)

  1994cited by this paper
• Identification of a syntaxin-binding site on N-type calcium channels.

  1994cited by this paper
• Substance P and somatostatin inhibit calcium channels in rat sympathetic neurons via different G protein pathways.

  1993cited by this paper
• Inhibition of Ca2+ currents by a mu-opioid in a defined subset of rat sensory neurons

  1993cited by this paper
• Substance P and somatostatin inhibit calcium channels in rat sympathetic neurons via different G protein pathwavs

  1993cited by this paper
• ω-Conotoxin GVIA blocks a Ca2+ current in bovine chromaffin cells that is not of the “classic” N type

  1992cited by this paper
• Biochemical properties and subcellular distribution of an N-type calcium channel alpha 1 subunit.

  1992cited by this paper
• Release of calcitonin gene-related peptide like-immunoreactivity induced by electrical field stimulation from rat spinal afferents is mediated by conotoxin-sensitive calcium channels.

  1992cited by this paper
• Molecular cloning of the alpha-1 subunit of an omega-conotoxin-sensitive calcium channel.

  1992cited by this paper
• Calcium Channels: Their Properties, Functions, Regulation, and Clinical Relevance

  1991cited by this paper
• Effect of omega conotoxin on reflex responses mediated by activation of capsaicin-sensitive nerves of the rat urinary bladder and peptide release from the rat spinal cord.

  1990cited by this paper
• Autoradiographic localization of calcium channels with [125I]ω-conotoxin in rat brain

  1988cited by this paper
• Autoradiographic localization of calcium channels with [125I]omega-conotoxin in rat brain.

  1988cited by this paper
• Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using omega-conotoxin from Conus magus venom.

  1987cited by this paper
• Calcium channel antagonists. Omega-conotoxin defines a new high affinity site.

  1986cited by this paper
• Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state.

  1984cited by this paper
• The ionic channels in excitable membranes.

  1975cited by this paper

• Intraneural delivery of CBD3A6K-RhB via PEG-PLGA nanoparticles for neuropathic pain therapy.

  2026cites this paper
• Anti-pain effect and mechanism of plant extracts in sensitive skin: A review

  2025cites this paper
• Noradrenergic α2 Receptor Modulates Cav2.2-Mediated Nociception in Parkinson’s Disease Through Spinal Neuro-glial Network

  2025cites this paper
• Calcium Channel α2δ Ligands Mirogabalin, Pregabalin, and Gabapentin: Advancements in Diabetic Peripheral Neuropathic Pain Therapeutics

  2025cites this paper
• Rodent Models of Diabetic Neuropathy, Role of Calcium Homeostasis in Pain and KB-R7943 as a Potential Therapeutic

  2025cites this paper
• Systemic antihyperalgesic effect of a novel conotoxin from Californiconus californicus in an inflammatory pain model

  2025cites this paper
• Voltage-Gated Ion Channels in Neuropathic Pain Signaling

  2025cites this paper
• Interleukin-1α links peripheral CaV2.2 channel activation to rapid adaptive increases in heat sensitivity in skin

  2024influential citation
• Light Therapy in Chronic Migraine

  2024cites this paper
• Inhibition of N-type calcium channels by phenoxyaniline and sulfonamide analogues

  2024cites this paper
• Peripheral CaV2.2 channels in skin regulate prolonged heat hypersensitivity during neuroinflammation

  2024cites this paper
• Peripheral CaV2.2 Channels in the Skin Regulate Prolonged Heat Hypersensitivity during Neuroinflammation

  2024influential citation
• N-Sulfonylphenoxazines as neuronal calcium ion channel blockers

  2024cites this paper
• Interleukin-1α links peripheral CaV2.2 channel activation to rapid adaptive increases in heat sensitivity in skin

  2024cites this paper
• Uncoupling the CRMP2-CaV2.2 interaction reduces pain-like behavior in a preclinical osteoarthritis model

  2024influential citation
• PDX1, a transcription factor essential for organ differentiation, regulates SERCA-dependent Ca2+ homeostasis in sensory neurons.

  2024cites this paper
• A versatile residue numbering scheme for Nav and Cav channels.

  2024cites this paper
• Uncoupling the CRMP2-CaV2.2 interaction reduces pain-like behavior in a preclinical joint-pain model.

  2024cites this paper
• A comprehensive review on ziconotide

  2024cites this paper
• Reductive amination of ω-conotoxin MVIIA: synthesis, determination of modification sites, and self-assembly

  2024influential citation
• Neuraxial drug delivery in pain management: An overview of past, present, and future.

  2023cites this paper
• Neuropilin-1 is essential for vascular endothelial growth factor A-mediated increase of sensory neuron activity and development of pain-like behaviors.

  2023cites this paper
• Synthesis of Cystine-Stabilised Dicarba Conotoxin EpI: Ring-Closing Metathesis of Sidechain Deprotected, Sulfide-Rich Sequences

  2023influential citation
• Self-Assembly Nanostructure of Myristoylated ω-Conotoxin MVIIA Increases the Duration of Efficacy and Reduces Side Effects

  2023influential citation
• An orally available Cav2.2 calcium channel inhibitor for the treatment of neuropathic pain

  2023influential citation
• N-type calcium channel blockers: a new approach towards the treatment of chronic neuropathic pain

  2023cites this paper
• Current Drug Development Overview: Targeting Voltage-Gated Calcium Channels for the Treatment of Pain

  2023cites this paper
• Capsaicin-Induced Endocytosis of Endogenous Presynaptic CaV2.2 in DRG-Spinal Cord Co-Cultures Inhibits Presynaptic Function

  2022cites this paper
• Targeting N-type calcium channels in young-onset of some neurological diseases

  2022cites this paper
• Normalization of Neuroinflammation: A New Strategy for Treatment of Persistent Pain and Memory/Emotional Deficits in Chronic Pain

  2022cites this paper
• Stingray Venom Proteins: Mechanisms of Action Revealed Using a Novel Network Pharmacology Approach

  2021cites this paper
• Regulation of Ion Channel Function by Gas Molecules.

  2021cites this paper
• Structure of human Cav2.2 channel blocked by the painkiller ziconotide

  2021cites this paper
• Mechanisms and Pathways of Pain Photobiomodulation: A Narrative Review.

  2021cites this paper
• Analgesic effects of Phα1β toxin: a review of mechanisms of action involving pain pathways

  2021cites this paper
• Discovery and Characterization of the Novel Conotoxin Lv1d from Conus lividus that Presents Analgesic Activity.

  2021cites this paper
• A Review on the Antidiabetic and Anticancer Activities of Conus Venom Peptides

  2021cites this paper
• Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery.

  2021cites this paper
• The neuronal calcium ion channel activity of constrained analogues of MONIRO-1.

  2020cites this paper
• Ziconotide for Management of Cancer Pain Refractory to Pharmacotherapy: An Update.

  2020cites this paper
• Non‐clinical characterization of the disposition of EMA401, a novel small molecule angiotensin II type 2 receptor (AT2R) antagonist

  2020cites this paper
• SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia

  2020cites this paper
• Capturing Novel Non-opioid Pain Targets.

  2020cites this paper
• Intercellular communication and ion channels in neuropathic pain chronicization

  2020cites this paper
• SARS-CoV-2 spike protein co-opts VEGF-A/neuropilin-1 receptor signaling to induce analgesia

  2020cites this paper
• Pain pathways and potential new targets for pain relief

  2020cites this paper
• Inflammation Induced Sensory Nerve Growth and Pain Hypersensitivity Requires the N-Type Calcium Channel Cav2.2

  2019cites this paper
• Neuropeptide FF (FLFQPQRF-NH2) and its Fragments Bind to α2δ Subunit of Voltage-Gated Calcium Channels.

  2019cites this paper
• Atomistic Simulations of Membrane Ion Channel Conduction, Gating, and Modulation.

  2019cites this paper
• Partners in Crime: Towards New Ways of Targeting Calcium Channels

  2019cites this paper
• Therapeutic benefits of maintaining mitochondrial integrity and calcium homeostasis by forced expression of Hsp27 in chemotherapy-induced peripheral neuropathy.

  2019cites this paper
• Pathological Factors Combine to Cause Hyperexcitability in Primary Afferent Neurons: Implications for Nociceptive Sensory Processing

  2018cites this paper
• CRMP2 and voltage-gated ion channels: potential roles in neuropathic pain

  2018cites this paper
• Conotoxin MVIIA improves cell viability and antioxidant system after spinal cord injury in rats

  2018cites this paper
• Discovery and optimization of a novel series of pyrazolyltetrahydropyran N-type calcium channel (Cav 2.2) blockers for the treatment of pain.

  2018cites this paper
• Chronic Neural Stimulation

  2018cites this paper
• Detection of Phenotypic Network Signatures in Cultured Neuronal Networks

  2017cites this paper
• Current and Future Issues in the Development of Spinal Agents for the Management of Pain

  2017cites this paper
• Calcium Signaling: From Physiology to Diseases

  2017cites this paper
• Cisplatin alters the function and expression of N-type voltage-gated calcium channels in the absence of morphological damage of sensory neurons

  2017cites this paper
• Long-lasting antinociceptive effects of green light in acute and chronic pain in rats

  2017cites this paper
• Introductory Chapter: Pain Relief - From Analgesics to Alternative Therapies

  2017cites this paper
• Magnetic Nanoparticle-Based Mechanical Stimulation for Restoration of Mechano-Sensitive Ion Channel Equilibrium in Neural Networks.

  2017cites this paper
• Cisplatin‐induced neuropathic pain is mediated by upregulation of N‐type voltage‐gated calcium channels in dorsal root ganglion neurons

  2017cites this paper
• Regulatory Action of Calcium in Pain Pathway

  2017cites this paper
• Acute and Chronic Neural Stimulation via Mechano-Sensitive Ion Channels

  2017cites this paper
• Changes in Ionic Conductance Signature of Nociceptive Neurons Underlying Fabry Disease Phenotype

  2017cites this paper
• Synthesis, Characterization and Pharmacological Evaluation of Thiosalicylamide Derivative as a Class of Calcium Channel Blocker

  2016cites this paper
• Optimization of a High-Throughput Assay for Calcium Channel Modulators on IonWorks Barracuda

  2016cites this paper
• ANALYSIS OF ADP RECEPTOR SIGNALING PATHWAYS IN NOCICEPTORS AND IMPLICATIONS FOR INFLAMMATORY PAIN

  2016cites this paper
• Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential

  2016cites this paper
• Antinociceptive activity of intraperitoneally administered novel and potent anticonvulsive compound, CY-PROLL-SS, in animal neuropathic pain models

  2016cites this paper
• Neurotoxische und neuroprotektive Mechanismen Cisplatin-induzierter Polyneuropathien

  2016cites this paper
• ω-conotoxin MVIIA intralesional injection in spinal cord injury in rats

  2015influential citation
• 3-Benzamides and 3,4,5-trimethoxyphenyl amines as calcium channel blockers.

  2015cites this paper
• Editorial: Voltage‐Gated Calcium 2.2 Channels: Therapeutic Target for Chronic Arthritic Pain?

  2015cites this paper
• Conotoxins That Could Provide Analgesia through Voltage Gated Sodium Channel Inhibition

  2015cites this paper
• Orofacial Pain Operant Analysis with Concomitant Investigation of Peripherally Restricted Cannabinoids and Nav1.8 Axonal Accumulation for the Potential Treatment of Neuropathic Pain

  2015cites this paper
• Imaging nociceptive signaling in peripheral CGRP terminal fibres

  2015influential citation
• An overview of the marine natural products in clinical trials and on the market

  2015cites this paper
• The Triggle effect.

  2015cites this paper
• ZC88, a novel N-type calcium channel blocker from 4-amino-piperidine derivatives state-dependent inhibits Cav2.2 calcium channels.

  2015cites this paper
• An introduction to pain pathways and pain "targets".

  2015cites this paper
• Phoneutria nigriventer Venom: Action in the Central Nervous System

  2015cites this paper
• Peripheral μ-opioid receptor mediated inhibition of calcium signaling and action potential-evoked calcium fluorescent transients in primary afferent CGRP nociceptive terminals.

  2015cites this paper
• Calcium Channel CaVα₁ Splice Isoforms - Tissue Specificity and Drug Action.

  2015cites this paper
• RESEARCH PAPER Effects of arginine 10 to lysine substitution on ω -conotoxin CVIE and CVIF block of Ca v 2.2 channels

  2014cites this paper
• Mechanism Of Gaba b Receptor-Activated Increases In L-Type Calcium Current In The Neonatal Mammalian Hippocampus

  2014cites this paper
• A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats.

  2014cites this paper
• Discovery of novel tetrahydroisoquinoline derivatives as orally active N-type calcium channel blockers with high selectivity for hERG potassium channels.

  2014cites this paper
• MODULAÇÃO DAS ALTERAÇÕES FUNCIONAIS E SINTOMÁTICAS RELACIONADAS À CISTITE HEMORRÁGICA INDUZIDA POR CICLOFOSFAMIDA EM CAMUNDONGOS ATRAVÉS DO BLOQUEIO MEDULAR DOS CANAIS DE CÁLCIO VOLTAGEM-DEPENDENTES DOS SUBTIPOS P/Q E N

  2014cites this paper
• Evaluating State Dependence and Subtype Selectivity of Calcium Channel Modulators in Automated Electrophysiology Assays

  2014cites this paper
• Huwentoxin-XVI, an analgesic, highly reversible mammalian N-type calcium channel antagonist from Chinese tarantula Ornithoctonus huwena.

  2014cites this paper
• Systemic effects induced by intralesional injection of ω-conotoxin MVIIC after spinal cord injury in rats

  2014cites this paper
• A mixed Ca2+ channel blocker, A-1264087, utilizes peripheral and spinal mechanisms to inhibit spinal nociceptive transmission in a rat model of neuropathic pain.

  2014cites this paper
• Characterization of the triazine, T4, a representative from a novel series of CaV2 inhibitors with strong state-dependence, poor use-dependence, and distinctively fast kinetics.

  2014cites this paper
• Mechanistic insights into the analgesic efficacy of A-1264087, a novel neuronal Ca(2+) channel blocker that reduces nociception in rat preclinical pain models.

  2014cites this paper
• Effects of arginine 10 to lysine substitution on ω‐conotoxin CVIE and CVIF block of Cav2.2 channels

  2014cites this paper
• Ph&agr;1&bgr;, a Peptide from the Venom of the Spider Phoneutria Nigriventer Shows Antinociceptive Effects after Continuous Infusion in a Neuropathic Pain Model in Rats

  2014cites this paper
• Spinal actions of ω‐conotoxins, CVID, MVIIA and related peptides in a rat neuropathic pain model

  2013influential citation